文献速递脑血管病外科神经重症

伴蛛网膜下腔出血的颅颈交界区动静脉瘘的临床特征与管理考量:一项多中心研究

Clinical Characteristics and Management Considerations of Craniocervical Junction Arteriovenous Fistulas With Subarachnoid Hemorrhage: A Multicenter Study.
PubMed 文献 · Neurosurgery · 2025-04-14

这项日本29中心多中心研究纳入111例颅颈交界区动静脉瘘患者,其中51例伴蛛网膜下腔出血。84%为轻型蛛网膜下腔出血(WFNS I或II级),再出血和症状性血管痉挛各占2%。急性手术组缺血并发症高于延迟手术组(P = .028),血管内治疗60%(6/10)需再治疗,最终mRS评分不因手术时机而异。

要点

  • 颅颈交界区动静脉瘘相关蛛网膜下腔出血多较轻,84%为WFNS I或II级,再出血与症状性血管痉挛各占2%。
  • 急性手术组并发症尤其是缺血并发症高于延迟手术组(P = .028)。
  • 血管内治疗60%(6/10)需再治疗,直接手术无需再治疗,最终mRS不因手术时机而异。

核心结论

  • 颅颈交界区动静脉瘘相关蛛网膜下腔出血常较轻,再出血/血管痉挛发生率低。
  • 与颅内动脉瘤性蛛网膜下腔出血不同,结果不支持将急性手术干预作为颅颈交界区动静脉瘘相关蛛网膜下腔出血的首选管理。
  • 通过延迟手术,临床医生可避免缺血并发症并改善患者结局。

研究设计与样本

  • 多中心研究,收集日本29个中心连续111例颅颈交界区动静脉瘘患者,其中51例伴蛛网膜下腔出血。
  • 分析血管解剖、诊断、治疗、手术时机和临床结局,采用二元逻辑回归识别并发症危险因素。

主要发现

  • 患者平均年龄67岁(范围33-85岁),男36例、女15例。
  • 84%的患者表现为轻型蛛网膜下腔出血(WFNS分级I或II级)。
  • 再出血和症状性血管痉挛各发生于2%的病例。
  • 初始治疗包括直接手术38例、血管内治疗10例、联合治疗3例。
  • 51例中,急性(发病3天内)9例(17.6%)、亚急性(4-14天内)9例(17.6%)、延迟(15天后)33例(64.7%)。

关键数值与推荐

  • 急性手术组并发症率高于延迟手术组,尤其缺血并发症(P = .028)。
  • 血管内治疗60%(6/10)需再治疗,直接手术无需再治疗。
  • 最终改良Rankin量表评分不因手术时机而异。

临床怎么用

  • 作者认为,结果不支持将急性手术干预作为颅颈交界区动静脉瘘相关蛛网膜下腔出血的首选管理。
  • 作者指出,通过延迟手术,临床医生可避免缺血并发症并改善患者结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Craniocervical junction (CCJ) arteriovenous fistulas (AVFs) presenting with subarachnoid hemorrhage (SAH) are rare conditions, with the optimal timing and approach to treatment still debated among neurosurgeons. The aim of this study was to characterize CCJ AVF-related SAH and determine appropriate surgical timing in a multicenter study. METHODS: Data from 111 consecutive patients with CCJ AVF, including 51 with SAH, were collected from 29 centers across Japan. The vascular anatomy, diagnosis, treatment, surgical timing, and clinical outcomes were analyzed. Binary logistic regression was used to identify risk factors for complications. RESULTS: The mean age of the patients was 67 years (range, 33-85 years), with 36 male patients and 15 female patients. Notably, a high percentage of patients (84%) presented with mild SAH (World Federation of Neurosurgical Societies grade I or II). Rebleeding and symptomatic vasospasm each occurred in 2% of cases. Initial treatments included direct surgery (n = 38), endovascular treatment (n = 10), and combined therapy (n = 3). Of the 51 patients, 17.6% (9/51) underwent acute (within 3 days of onset), 17.6% (9/51) subacute (within 4-14 days), and 64.7% (33/51) delayed procedures (after 15 days). Our study revealed a higher rate of complications, especially ischemic complications ( P = .028), in patients who underwent acute surgery than in those who underwent delayed procedures. Endovascular treatment required retreatment in 60% (6/10) of cases, whereas direct surgery did not necessitate retreatment. The final modified Rankin Scale scores did not differ based on surgical timing. CONCLUSION: CCJ AVF-related SAH is often mild, as evidenced by a high proportion of patients with low-grade World Federation of Neurosurgical Societies scores and a low rate of rebleeding/vasospasm. In contrast to intracranial aneurysmal SAH, our results do not support acute surgical intervention as the preferred management for patients with CCJ AVF-related SAH. Through delayed surgery, clinicians can avoid ischemic complications and improve patient outcomes.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Inoue T, Endo T, Takai K, et al. Clinical Characteristics and Management Considerations of Craniocervical Junction Arteriovenous Fistulas With Subarachnoid Hemorrhage: A Multicenter Study. Neurosurgery. 2025. PMID: 40227047. doi:10.1227/neu.0000000000003444

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。